Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 841 AL 855

Comparison of the effect of online physical exercise and computerized cognitive stimulation in patients with Alzheimer's disease during the Covid-19 pandemic

Akbuga Koc E, Yazici-Mutlu Ç, Cinar N, Sahiner T.

Complement Ther Clin Pract. 2024 Nov;57:101881. doi: 10.1016/j.ctcp.2024.101881. Epub 2024 Jul 1.

Exploring the therapeutic potential of steroidal alkaloids in managing Alzheimer's disease

Pandey PP, Kumar MS.

Steroids. 2024 Sep;209:109468. doi: 10.1016/j.steroids.2024.109468. Epub 2024 Jul 2.

Nutrition guidance within a multimodal intervention improves diet quality in prodromal Alzheimer's disease: Multimodal Preventive Trial for Alzheimer's Disease (MIND-AD(mini))

Levak N, Lehtisalo J, Thunborg C, Westman E, Andersen P, Andrieu S, Broersen LM, Coley N, Hartmann T, Irving GF, Mangialasche F, Ngandu T, Pantel J, Rosenberg A, Sindi S, Soininen H, Solomon A, Wang R, Kivipelto M.

Alzheimers Res Ther. 2024 Jul 3;16(1):147. doi: 10.1186/s13195-024-01522-8.

Unique Properties of Synaptosomes and Prospects for Their Use for the Treatment of Alzheimer's Disease

Dashkova AS, Kovalev VI, Chaplygina AV, Zhdanova DY, Bobkova NV.

Biochemistry (Mosc). 2024 Jun;89(6):1031-1044. doi: 10.1134/S0006297924060051.

Resistance Exercise Training as a New Trend in Alzheimer's Disease Research: From Molecular Mechanisms to Prevention

Sepúlveda-Lara A, Sepúlveda P, Marzuca-Nassr GN.

Int J Mol Sci. 2024 Jun 27;25(13):7084. doi: 10.3390/ijms25137084.

Current View on PPAR-α and Its Relation to Neurosteroids in Alzheimer's Disease and Other Neuropsychiatric Disorders: Promising Targets in a Therapeutic Strategy

Żulińska S, Strosznajder AK, Strosznajder JB.

Int J Mol Sci. 2024 Jun 28;25(13):7106. doi: 10.3390/ijms25137106.

Novel Leptin-Based Therapeutic Strategies to Limit Synaptic Dysfunction in Alzheimer's Disease

Harvey J.

Int J Mol Sci. 2024 Jul 4;25(13):7352. doi: 10.3390/ijms25137352.

Chiral pyrrolidines as multipotent agents in Alzheimer and neurodegenerative diseases

Carrieri A, Barbarossa A, de Candia M, Samarelli F, Damiano Altomare C, Czarnota-Łydka K, Sudoł-Tałaj S, Latacz G, Handzlik J, Brunetti L, Piemontese L, Limongelli F, Lentini G, Carocci A.

Bioorg Med Chem. 2024 Aug 1;110:117829. doi: 10.1016/j.bmc.2024.117829. Epub 2024 Jul 3.

Phytochemicals targeting mitophagy: Therapeutic opportunities and prospects for treating Alzheimer's disease

Yang J, Zhao H, Qu S.

Biomed Pharmacother. 2024 Aug;177:117144. doi: 10.1016/j.biopha.2024.117144. Epub 2024 Jul 14.

Developing public-private R&D consortia to accelerate Alzheimer's disease drug development

West J, Olk P.

Drug Discov Today. 2024 Sep;29(9):104103. doi: 10.1016/j.drudis.2024.104103. Epub 2024 Jul 15.

Drugs targeting APOE4 that regulate beta-amyloid aggregation in the brain: Therapeutic potential for Alzheimer's disease

Poblano J, Castillo-Tobías I, Berlanga L, Tamayo-Ordoñez MC, Del Carmen Rodríguez-Salazar M, Silva-Belmares SY, Aguayo-Morales H, Cobos-Puc LE.

Basic Clin Pharmacol Toxicol. 2024 Sep;135(3):237-249. doi: 10.1111/bcpt.14055. Epub 2024 Jul 17.

Design of Multi-Target drugs of HDACs and other Anti-Alzheimer related Targets: Current strategies and future prospects in Alzheimer's diseases therapy

Soltan OM, Abdelrahman KS, Bass AKA, Takizawa K, Narumi A, Konno H.

Bioorg Chem. 2024 Oct;151:107651. doi: 10.1016/j.bioorg.2024.107651. Epub 2024 Jul 15.

Cannabidiol and Alzheimer's disease

Marques BL, Campos AC.

Int Rev Neurobiol. 2024;177:121-134. doi: 10.1016/bs.irn.2024.04.014. Epub 2024 Jul 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias